MGHL News

Morgan Stanley posts Q4 earnings beat driven by wealth management, investment banking growth

Morgan Stanley (NYSE:MS) shares rose 4% after the firm delivered strong fourth quarter earnings that exceeded Wall Street expectations on both revenue and earnings per share (EPS). The bank posted net revenues of $17.89 billion, surpassing the consensus estimate of $17.66 billion, marking 10.3% year-over-year growth driven by strength in wealth management.

Proactiveinvestors | 5 months ago

Morgan Stanley Q4 Review: Strong Fundamentals Priced In (Downgrade)

Morgan Stanley delivered strong Q4 results, with 10% revenue growth and 21.8% return on tangible common equity. MS's wealth management business drove record advisory revenue, robust inflows, and margin expansion, reinforcing its fee-based, recurring revenue model. The bank's capital position remains excellent, supporting ongoing buybacks and a secure 2.2% dividend yield.

Seekingalpha | 5 months ago

Morgan Stanley tops estimates driven by wealth management

CNBC's Leslie Picker reports on the company's quarterly earnings results.

Youtube | 5 months ago

Morgan Stanley is about to report earnings. Here's what to expect

Stocks are trading at record highs, which could provide a boost to Morgan Stanley's massive wealth management business.

Cnbc | 5 months ago

Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

Zealand Pharma A/S (ZLDPF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

JP Morgan cautious ahead of reporting season in oil sector

Analysts at JPMorgan repeated a cautious stance on European oil and gas equities into 4Q reporting season, with the American bank highlighting a more challenging 2026 backdrop as oversupply risks are seen as building. The bank also flagged valuation and expectations.

Proactiveinvestors | 5 months ago

Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 5 months ago

Morgan Group Holding Co. (MGHL)